Randomized controlled trials are rarely feasible for every cardiovascular device, making real-world observational data increasingly important. However, these analyses are often criticized for lacking rigor. A Harvard research team published a comprehensive review in Circulation outlining how to conduct high-quality observational studies on cardiovascular devices. They center their approach on the 'target trial framework,' which organizes an observational study by asking three key questions: What is the research question? What data and methods are available? And what specific steps should be taken? This structured approach helps researchers minimize bias and generate credible causal evidence. For clinicians and patients, this means that real-world evidence supporting device approvals and clinical guidelines could become substantially more reliable when these methods are applied consistently.
